Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.

ABSTRACT:

Background

Antithrombotic prophylaxis with oral anticoagulation (OAC) substantially reduces stroke and mortality in patients with atrial fibrillation (AF).

Hypothesis

Analysis of data in the Global Registry on Long-Term Antithrombotic Treatments in Patients With Atrial Fibrillation (GLORIA-AF), an international, observational registry of patients with newly diagnosed AF, can identify factors associated with treatment decisions and outcomes.

Methods

Multivariable regression identified patient, physician, and temporal factors associated with OAC prescription, compared with management with antiplatelet drugs or no antithrombotic drugs in North American patients enrolled between November 2011 and February 2014.

Results

Of 3320 eligible patients (mean age, 71 ± 11 y

SUBMITTER: McIntyre WF 

PROVIDER: S-EPMC6032943 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature